A Clinical Trial of Ginseng in Diabetes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

EARLY_PHASE1

Total Enrollment

19 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-09-30

Study Completion Date

2008-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

a clinical study of Ginseng its potential affect on diabetes

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy and Safety of Hydrolyzed Ginseng Extract on Impaired Fasting Glucose

NCT01854164

Hyperglycemia

COMPLETED NA

Effect of Ginseng in Type 2 Diabetes

NCT02923453

Type II Diabetes Control

COMPLETED PHASE2

The Effect of Korean Red Ginseng Supplementation on Glucose Control

NCT01911663

Diabetes

COMPLETED PHASE4

Efficacy and Safety of Hydrolysed Red Ginseng Extract on Improvement of Hyperglycemia

NCT03775733

Hyperglycemia

UNKNOWN NA

Effect of Ginseng on Glycemic Control

NCT01841229

Impaired Glucose Tolerance Diabetes

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Comparing three groups (those with \& without normal blood sugar levels) to see if there is any clinically significant change in blood sugar levels in relationship to those taking:

1. ginseng
2. ginsenoside RE (a type of metabolized ginseng)
3. placebo

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1. Ginseng

Ginseng group

Group Type ACTIVE_COMPARATOR

Ginseng

Intervention Type DRUG

Each of the 3 arms will be compared to determine if there is any clinical difference in blood sugars between the 3 groups

2. Ginsenosdie RE

Ginsenoside RE (a metabolite of ginseng) group

Group Type ACTIVE_COMPARATOR

Ginseng

Intervention Type DRUG

ginsenoside RE

Intervention Type DRUG

active metabolite of ginseng

3. Placebo

placebo ("sugar" pill) group

Group Type PLACEBO_COMPARATOR

Placebo (sugar pill)

Intervention Type DIETARY_SUPPLEMENT

placebo group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ginseng

Each of the 3 arms will be compared to determine if there is any clinical difference in blood sugars between the 3 groups

Intervention Type DRUG

Ginseng

Intervention Type DRUG

ginsenoside RE

active metabolite of ginseng

Intervention Type DRUG

Placebo (sugar pill)

placebo group

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ages 18-65
* healthy, non-diabetic
* healthy, impaired glucose tolerance/mild diabetes (no medications required)

Exclusion Criteria

* impaired glucose tolerance (borderline diabetes that requires medications)
* diabetes (requiring medications)
* caffeine sensitivity
* known cardiac, peripheral vascular diseases
* arrhythmias (irregular heart rhythms)

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes